Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
Crossref DOI link: https://doi.org/10.1038/s41598-021-86485-8
Published Online: 2021-03-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Jianhua
Zhao, Qun
Zhao, Yue
Zhang, Xiaoyun
Tian, Yuan
Guo, Zhanjun
Text and Data Mining valid from 2021-03-26
Version of Record valid from 2021-03-26
Article History
Received: 16 February 2020
Accepted: 8 March 2021
First Online: 26 March 2021
Competing interests
: The authors declare no competing interests.